Venture Capital Investors Like Revenue, But They Love Predictable Revenue

For any startup, generating that first dollar is a huge milestone. Revenue signals to investors that a company is helping to solve a problem in the market, and even more importantly, that people are willing to pay for that solution. If you are an entrepreneur that has reached this point, we truly applaud you—many startups

Read Story

Sparking Innovation In Akron

Nick Petroski had become frustrated by the lack of startup events being held in Akron. The Launch League co-founder and board chairman was aware of a few weekend-long events in the area, but felt they didn’t fully encapsulate the highs and lows of building something. Taking matters into his own hands, he and his wife,

Read Story

IP Workshop With Isaac Molnar

On Thursday, January 12, JumpStart hosted an IP workshop with Isaac Molnar, Assistant Attorney General and Intellectual Property Counsel, Business Counsel Unit for the State of Ohio. This program focused on issues unique to web-based/software/app-based (“IT”) companies. The first topic, Intellectual property or IP, refers to trademark, trade secrets, patent and copyright law. Each of these

Read Story

How To Hire Your First Employee

Your business is growing and so is the workload. At this point, your young startup is likely seeking additional bandwidth, new skills and maybe even a fresh perspective. All of which can be obtained by adding a new member to the team. Hiring your first employee is huge step forward for your company, but that

Read Story

How Does A Lead Become A Customer?

You’ve likely heard it before, “think of the marketing and sales cycle as a funnel.” But what does that actually mean, and how can you apply an understanding of this funnel to help generate paying customers? Let’s start by considering the funnel’s basic goal and identifying the stages of the sales cycle that help you

Read Story

Entrepreneur Insight: Al Hawkins, Milo Biotechnology

Driven by the rarity of the disease and the fact that there were no viable therapies on the market, Al Hawkins set out on a mission to enhance the lives of patients diagnosed with debilitating and incurable muscular dystrophies. In 2012, he founded Milo Biotechnology, a clinical-stage startup working to develop gene therapies to treat

Read Story